Skip to main content
Instil Bio, Inc. logo

Instil Bio, Inc. — Investor Relations & Filings

Ticker · TIL ISIN · US45783C2008 LEI · 529900HW1XOEQEVG5T88 US Manufacturing
Filings indexed 239 across all filing types
Latest filing 2025-04-28 Director's Dealing
Country US United States of America
Listing US TIL

About Instil Bio, Inc.

https://instilbio.com/

Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops novel cell therapies for the treatment of cancer. The company's work has centered on developing a pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies designed to target solid tumors. Its lead asset is AXN-2510, a therapeutic candidate for solid tumor cancers.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2025-04-28 English
ARS
Annual Report
2025-04-14 English
DEFA14A
Regulatory Filings
2025-04-14 English
DEF 14A
Proxy Solicitation & Information Statement
2025-04-14 English
424B5
Regulatory Filings
2025-03-31 English
8-K
Regulatory Filings
2025-03-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.